This document outlines an exclusive GP-led secondary deal for Project Klein under SOF IV, expected to close in June 2018. It involves a mid-market buyout strategy in Europe/UK, focusing on business and healthcare services. The investment includes four companies, with key assets in UK premium distribution and medical/cosmetics clinics. The deal is positioned to leverage market tailwinds and cost efficiency initiatives.
documents/vol00010-efta01354881-pdf.pdf
{"title":"SOF IV — Project Klein","key_people":["Glendower Team"],"document_date":"June 2018","document_type":"tabular","key_locations":["Europe","UK","Italy"],"document_subtype":"investment summary","key_organizations":["Glendower Capital"]}